Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
Recruiting
N/A
Interventional Study
Enlarged Prostate (BPH)
Benign Prostatic Hyperplasia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 100
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 180 (estimated)
- Sponsor
- Northwestern University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
* Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion Criteria:
* Patients who lack decisional capacity
* Patients unabl…
Contacts